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BRIEF
APRIL 2014

MEASURING THE IMPACT OF
CONTRACEPTIVE USE ON
UNINTENDED PREGNANCY AND
OTHER HEALTH OUTCOMES
National and global support for
services that enable women and their
partners to have access to a full range
of quality contraceptives are growing
rapidly, as evidenced through the
financial commitments made during
the London Summit on Family Planning,
and the ensuing FP2020 Initiative that
seeks to reduce unmet need for such
services by 120 million women.
With these investments, and the anticipated increases
in effective contraceptive use, come expectations of substantial and demonstrable impacts on a range of health
outcomes, including significant reductions in unintended
pregnancies, maternal, newborn and child deaths and
unsafe abortions.
Attributing health outcomes to a specific health intervention is always challenging, and direct measurement of
outcomes averted is not possible. Consequently, several
statistical models have been developed that estimate the
number of health outcomes that will be averted because
of contraceptive use. The table on page 3 describes and
compares five of the most commonly used approaches:
Adding it Up (AIU); Impact2; ImpactNow; Reality Check;
and FamPlan/LiST. AIU is used by staff at the Guttmacher Institute for undertaking and presenting analyses of
outcomes and is not in the public domain; the other four
estimation models have been developed for use at national
and sub-national levels by donors, programme managers
and policymakers. While these are the most frequently
used approaches to measure the impact of contraceptive use, other models are available that address similar

APPROACHES FOR MEASURING
THE IMPACT OF CONTRACEPTIVE USE
Adding it up (AIU)
ORGANISATION: Guttmacher Institute
CONTACT: Jacqueline E. Darroch

(JEDarroch@guttmacher.org)

WEBSITE: Darroch, J, Singh S. 2011. Adding It Up:

The Costs And Benefits Of Investing In
Family Planning And Maternal And Newborn
Health—Estimation Methodology. New York:
Guttmacher Institute.
www.guttmacher.org/pubs/AIU-methodology.pdf
Impact2

ORGANISATION: Marie Stopes International
CONTACT: Michelle Weinberger

(michelle.weinberger@mariestopes.org)

WEBSITE: Marie Stopes International. 2012. Impact 2:

An innovative tool for measuring the impact of
reproductive health programmes. London:
Marie Stopes International.
www.mariestopes.org/impact-2
ImpactNow

ORGANISATION: USAID Health Policy Project, Futures

Group

CONTACT: Ellen Smith

(esmith@futuresgroup.com)

WEBSITE: Not yet available

Reality Check
ORGANISATION: USAID RESPOND Project, EngenderHealth
CONTACT: Melanie Yahner

(myahner@engenderhealth.org)

WEBSITE: Not yet available www.respond-project.org

FamPlan/LiST
ORGANISATION: USAID Health Policy Project, Futures

Institute

CONTACT: John Stover

(jstover@futuresinstitute.org)

WEBSITE: Spectrum Manual: Spectrum System of Policy

Models: www.futuresinstitute.org/spectrum.aspx

questions. The Crosswalk document1 helps advocates,
programme planners, decision makers, and others select
which among these tools might best address their goals or
questions, as well as provide insight into how to interpret the
outputs of each tool.
However, concerns have been expressed that this range of
approaches—which overlap in the impacts they estimate, but
sometimes use different inputs, mathematical algorithms and
assumptions, and may produce different results—may be
confusing for policy makers, managers and donors who want
to measure or evaluate these impacts. To address these
concerns, the STEP UP consortium convened two expert
meetings (in September 2013 and March 2014) to review the
estimation methods used; come to consensus on methodologies and assumptions, where possible; and provide guidance
to those wanting to measure such impacts. Following the
first meeting, the same data from four countries (Bangladesh,
Burkina Faso, Colombia, Malawi) were inputted into each
model and the estimates generated for numerous impacts
were compared. Substantial differences emerged, which
provided the basis for intensive discussions between the
model developers during the second meeting. These discussions led to modifications in the models through reaching a
consensus on the following core elements.

PREGNANCY RATES
Pregnancy rates are important for determining the likelihood
of a pregnancy among sexually active, fecund women who
do not want to become pregnant when contraception is not
used. Agreement was reached that the same pregnancy rate
for a “non-user at risk of unintended pregnancy” should be
used as the default where applicable in all models and kept
constant for the foreseeable future. Using the AIU methodology, the estimated pregnancy rate among women with unmet
need using no method across 148 developing countries is
31%, with an inter-quartile plausibility range of 23-38%. This
rate is calculated by dividing the number of unintended pregnancies among the estimated number of women with unmet
need using no method, by the total number of women with
unmet need using no method. This rate is lower than some
previous estimates. It should be noted that this default pregnancy rate will be adopted by the models Impact2, ImpactNow, Reality Check and FamPlan but the published tables in
Adding It Up will continue to use Guttmacher’s estimates of
regional pregnancy rates.
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CONTRACEPTIVE METHOD FAILURE RATES
Agreement was reached that the same method failure rates
should be used where applicable in all models because it is
important to ensure that the estimated impact of using contraception takes into account the fact that no method is 100%
effective. The group recommended using the method-specific rates calculated by Cleland, Ali & Shah1 and by Trussell.2
Moreover, agreement was reached that these rates should
not be adjusted for individual countries because: i) it is not
possible to distinguish unintended pregnancy by method
used in national settings; and ii) these global estimates are
widely accepted. As with the pregnancy rates, this consensus will be implemented by the models Impact 2, ImpactNow,
Reality Check and FamPlan; the Adding It Up analysis will
continue to be based on the adjusted failure rates estimated
by Guttmacher staff, which differ by region.

ESTIMATING ABORTIONS AND
MISCARRIAGES AVERTED
AIU, Reality Check, and FamPlan will use the “% of unintended pregnancies ending in abortion” rates estimated by the
Guttmacher Institute. Impact2 and ImpactNow currently apply
sub-regional abortion ratios to the number of live births averted, and will explore using the Guttmacher Institute’s unintended pregnancy ratios instead. The models estimate the number
of miscarriages averted slightly differently, but the differences
are very minor and so no change was deemed necessary.

MATERNAL DEATHS AVERTED
Published national maternal mortality ratios (MMR) represent
the overall risk of maternal mortality given the national distribution of pregnancy outcomes (births, abortions, miscarriages). Applying these ratios to estimates of live births averted
by contraceptive use does not accurately represent the risk
of maternal mortality of an adjusted distribution on unintended pregnancies (see above). Reality Check and FamPlan will
adapt the AIU approach to adjusting the national maternal
mortality ratio estimations,4 to reflect the adjusted distribution
of unintended pregnancy outcomes. This adjustment will
be done using WHO sub-regional unsafe abortion rates and
a Guttmacher Institute estimate of two deaths per 100,000
safe abortions. Impact2 and ImpactNow will explore using
this adjusted approach as part of exploring adjusting pregnancy outcomes based on pregnancy intention.

Godbole R, Smith E. 2012. Crosswalk of Family Planning Tools: A Guide to Costing, Planning, and Impact Analysis Tools. Washington, DC: Health Policy
Project, USAID, Bureau for Global Health.
Cleland J, Ali MM, and Shah I. 2006. “Dynamics of contraceptive use”, in: UN Department of Economic and Social Affairs, Population Division, Levels and
Trends of Contraceptive Use as Assessed in 2002, pp. 87–115, Table 22, page 98.
Trussell J. 2007. “Contraceptive efficacy,” in: Hatcher RA et al. (eds.), Contraceptive Technology, 19th ed., New York: Ardent Media.
http://maternalmortalitydata.org/mme.html

METHOD USED TO
ESTIMATE NUMBER
OF INFANT AND CHILD
DEATHS AVERTED
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ESTIMATE NUMBER
OF MATERNAL
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OF ABORTIONS
AVERTED

OUTCOMES MEASURED

DATA INPUT REQUIREMENTS

PURPOSES

COMMONLY USED APPROACHES TO ESTIMATING THE IMPACT OF CONTRACEPTIVE USE
Adding It Up
Guttmacher Institute

Impact 2
MSI

ImpactNow
Futures Group

Reality Check
EngenderHealth

FamPlan/LiST
Futures Institute

Illustrate the health and
financial costs and benefits
of modern contraceptive use
in terms of outcomes averted
through current or full (i.e.
no unmet need) contraceptive use.

Estimate the current and potential
future impacts of FP service
provision on adverse outcomes
averted through comparing current
contraceptive use (modelled from
service statistics) with no use;

Estimate the health and economic impacts of contraceptive
use in the near-term; automatic
scenario comparisons facilitate
creation of advocacy messages.
Can also estimate impacts for a
given FP budget.

Estimate the resources
required to maintain or reach
a specified contraceptive
prevalence, increase by a
certain annual rate, or meet
unmet need;

Estimate the resources required to
meet contraceptive goals, such as
reducing unmet need, achieving
a specified modern contraceptive
prevalence gaol, or achieving a
goal of reduced total fertility.

No input required from user.

Required input from user:

Tabulations of most recent
national surveys (e.g. DHS,
MICS); estimations for
missing data:

Quantity of services provided
annually; or programme goal (CPR,
additional users).

The following inputs have default
values, which can be overridden
by the user:

The following inputs have
default values which can be
overridden by the user:

Estimate the quantity of contraceptive services needed to reach a
specified contraceptive prevalence
goal.

Estimate the potential impact
of achieving this goal on
averting adverse outcomes.

− Demographic data from UN
− Method discontinuation,
Population Projections;
CYP factors, per-unit costs,
− DHS and UN Population
pregnancy rate, unintended
Division data on CPR, unmet
pregnancy outcomes,
need, % Married;
maternal mortality ratio;
− Special studies for method
− Tabulations of most recent
effectiveness and discontinnational surveys (e.g. DHS,
uation;
MICS) for CPR;
− Costs & coverage by of mater- − Demographic data from
nal & neonatal interventions
UN Population Projections.
from UN Reproductive Health
Costing Tool and others;
− Unit costs of FP provision (by
method).

− Demographic data on population by age and sex in base
year, TFR, age distribution of
fertility, sex ratio at birth, life
expectancy at birth, migration
by age and sex from UN Population Projections.
− DHS data on method mix, source
mix, proximate determinants of
fertility, costs of FP by method
and source, method effectiveness, CYP factors, and percent
of births that are high risk;
− Data from special studies for
method effectiveness and CYP
factors.
Programme outcomes:
− TFR;
− CPR;
− FP users and acceptors, by
method and source;
− Unmet need;
− Average method effectiveness;
− CYP;
− Commodities required;
− Contraceptive service costs;
− Percentage of births with
demographic risk factors;
− Pregnancies;
− Births by mother’s age, birth
interval and parity;
− Abortions;
− Maternal deaths, by type;
− Infant and under 5 mortality rates

− Method use;
− Unmet need (by marital
status and spacing/
limiting);
− Sub-regional estimates
of unintended pregnancies
− Estimated proportions of
pregnancy outcomes for
birth, safe/unsafe abortion
and miscarriage;
− Maternal death rate and
DALYs (for all women and
those with abortions).

The following inputs have defaults
which can be overridden by the
user:
− Demographic data from UN
Population Projections;
− DHS and UN Population Division data on CPR, unmet need,
% married;
− Special studies for method
effectiveness and CYP factors;
− Costs & coverage by of maternal & neonatal interventions
from UN Reproductive Health
Costing Tool

Impacts estimated:

Programme outcomes:

Programme outcomes:

Programme outcomes:

− Unintended pregnancies;
− Unintended births (live
& still);
− Safe & unsafe abortions;
− Miscarriages;
− Maternal deaths;
− DALYs;
− Contraceptive service
costs;
− Maternal and newborn
health care costs.

− FP users by method
− Contribution to CPR
− Services needed to reach goal

− FP users and acceptors, by
method
− CPR;
− Unmet need;
− FP budget required (depending on configuration chosen)

− FP users and acceptors;
− Commodities
Commodity costs

Impacts averted:
− Unintended pregnancies;
− Live births;
− Safe & unsafe abortions;
− Maternal & child deaths;
− DALYs;
− Direct costs saved to families
and healthcare systems (maternal & neonatal).

The following inputs have default
values preloaded, which cannot be
overridden by the user:

Impacts averted:
− Unintended pregnancies;
− Live births;
− Safe & unsafe abortions;
− Maternal & child deaths;
− DALYs;
− Maternal & neonatal costs
averted;
− Cost-benefit ratio;
− ICER (Incremental CostEffectiveness Ratio).

Impacts averted:
− Unintended pregnancies;
− Live births;
− Safe & unsafe abortions;
− Maternal deaths.

Impacts averted:
− Impacts can be calculated
for any of the programme
outcomes listed above

Apply current proportion of
sub-regional unintended
pregnancies that end in
abortions (safe & unsafe)
to unintended pregnancies
averted.

Apply sub-regional abortion ratios
to the number of live births averted
nationally; Live births averted
calculated by subtracting estimated
abortions, stillbirths, and miscarriages from pregnancies averted.

Apply sub-regional abortion
ratios to the number of live
births averted nationally; Live
births averted calculated by
subtracting estimated abortions,
stillbirths, and miscarriages from
pregnancies averted.

Apply current proportion of
sub-regional unintended
pregnancies that end in
abortions (safe & unsafe)
to unintended pregnancies
averted.

Number of abortions calculated
from an assumed total abortion
rate, or as a percentage of
unintended pregnancies.

Apply mortality ratios for live
births, safe & unsafe abortions averted; Ratios based
on WHO country MMR,
WHO regional unsafe abortion mortality and estimated
safe abortion mortality.

Apply the national maternal mortality ratio to the number of live births
averted Default MMR values from
WHO provided.

Apply the national maternal
mortality ratio to the number of
live births averted. Default MMR
values from WHO provided.

Apply MMR to number of live
births averted. Default MMR
values from WHO provided.

Apply MMR to the number of live
births.

Attribute infant mortality
reduction to fewer births.

Country-specific coefficient applied
to the number of live births; this
coefficient estimates the effect of
longer birth intervals on decreasing
child mortality.

Country-specific coefficient
applied to the number of live
births; this coefficient estimates
the effect of longer birth intervals
on decreasing child mortality.

Infant and child deaths
averted are not outputs of
the tool.

Apply coefficient developed using
PSI methodology for birth spacing
impact.

Apply coefficient developed
using PSI methodology for birth
spacing impact.

Deaths averted result from two factors: 1) contraception leads to fewer
births which result in fewer deaths,
2) contraception leads to fewer
risky births (high parity, closely
spaced, mother’s age <18 or >35)
which can reduce mortality rates
and thus result in fewer deaths.

Apply WHO or IHME mortality rates to unplanned births
averted.
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INFANT AND CHILD DEATHS AVERTED
The estimates of infant and child deaths averted are recognized as the weakest elements of these models because
the relationship between contraceptive use and infant and
child mortality is still being clarified. However, these impacts
are requested by many users for advocacy purposes and
so all models are looking to improve the estimation methods; for example, Impact2 and FamPlan are exploring how
contraceptive use changes the distribution of birth spacing
risks and subsequent child mortality. AIU currently estimates
infant deaths averted due to a reduction in the number of
births (i.e. the demographic effect), rather than changes in
risk and will explore integrating findings regarding changes
in birth spacing.
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IMPLICATIONS FOR MEASURING THE
IMPACT OF CONTRACEPTIVE USE
These meetings and modelling exercises provided an important and unique opportunity for those involved in the development of estimation methodologies to come together and to
discuss the various approaches used. This review process
enabled the group to identify where and why differences
existed and to seek alignment for harmonising the modelling approaches more closely. As a result, the estimation
methodologies for each approach have been coordinated
and consensus reached to ensure that, wherever possible, they are not in conflict. This alignment and consensus
building process has strengthened the models by enabling
their developers to benefit from each other’s’ experience
and research. Moreover, decision-makers and managers
using the different models can more clearly understand the
assumptions behind each model so as to make informed
choices between them.

STEP UP generates policy-relevant research to
promote an evidence-based approach for improving
access to family planning and safe abortion services.
We work in Bangladesh, northern India, Ghana,
Kenya, and Senegal.
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